7172
X.-S. Wang et al. / Tetrahedron Letters 46 (2005) 7169–7173
14. (a) Wang, X. S.; Shi, D. Q.; Li, Y. L.; Chen, H.; Wei, X.
Y.; Zong, Z. M. Synth. Commun. 2005, 35, 97; (b) Shi, D.
Q.; Zhang, S.; Zhuang, Q. Y.; Wang, X. S.; Tu, S. J.; Hu,
H. W. Chin. J. Chem. 2003, 21, 680; (c) Wang, X. S.; Shi,
D. Q.; Zhang, Y. F.; Wang, S. H.; Tu, S. J. Chin. J. Org.
Chem. 2004, 24, 430.
15. The general procedure for 3 and 5 is presented as follows:
A mixture of Schiff base 1 or 4 (2 mmol), dimedone 2
(2 mmol) and TEBA (0.1 g) was suspended in water
(10 mL) and stirred at 100 ꢁC for several hours. Upon
completion, monitored by TLC, the reaction mixture was
allowed to cool to room temperature. The crystalline
powderwas collected by filtration, washed with waterand
recrystallized from DMF and water mixture to give pure
acridine derivatives 3 or 5. Compound 3a: mp 263–266 ꢁC;
1H NMR: d 0.98 (s, 3H, CH3), 1.08 (s, 3H, CH3), 2.05 (d,
J = 16.0 Hz, 1H, CH), 2.25 (d, J = 16.0 Hz, 1H, CH), 2.66
(d, J = 16.8 Hz, 1H, CH), 2.73 (d, J = 16.8 Hz, 1H, CH),
5.23 (s, 1H, CH), 7.18–7.28 (m, 5H, ArH), 7.46–7.53 (m,
2H, ArH), 7.57–7.60 (m, 1H, ArH), 7.83 (d, J = 8.4 Hz,
1H, ArH), 8.47 (d, J = 8.4 Hz, 1H, ArH), 9.31 (s, 1H,
NH); IR (KBr, m, cmꢀ1): 3307, 2954, 1672, 1589, 1518,
1384, 1261, 1151, 1089, 1060, 1014, 850, 806, 756. Anal.
Calcd forC 25H22ClNO: C, 77.41; H, 5.72; N, 3.61. Found:
C, 77.34; H, 5.88; N, 3.60. Compound 3h: mp > 300 ꢁC;
1H NMR: 1.08 (s, 3H, CH3), 1.12 (s, 3H, CH3), 2.05 (d,
J = 16.0 Hz, 1H, CH), 2.24 (d, J = 16.0 Hz, 1H, CH), 2.04
(d, J = 17.2 Hz, 1H, CH), 2.69 (d, J = 17.2 Hz, 1H, CH),
5.11 (s, 1H, CH), 6.65 (d, J = 8.4 Hz, 2H, ArH), 7.00 (d,
J = 8.4 Hz, 2H, ArH), 7.49 (d, J = 8.8 Hz, 1H, ArH), 7.55
(d, J = 8.8 Hz, 1H, ArH), 7.57–7.59 (m, 1H, ArH), 8.84 (d,
J = 4.4 Hz, 1H, ArH), 8.90 (d, J = 8.4 Hz, 1H, ArH), 9.12
(s, 1H, NH), 9.35 (s, 1H, OH). IR (KBr, m, cmꢀ1): 3286,
3197, 2957, 1693, 1569, 1490, 1415, 1382, 1262, 1248, 1155,
1066, 831, 790. Anal. Calcd forC 24H22N2O2: C, 77.81; H,
5.99; N, 7.56. Found: C, 77.61; H, 5.87; N, 7.60.
Compound 5a: mp > 300 ꢁC; 1H NMR: 0.84 (s, 3H,
CH3), 1.03 (s, 3H, CH3), 2.02 (d, J = 16.0 Hz, 1H, CH),
2.23 (d, J = 16.0 Hz, 1H, CH), 2.39 (d, J = 16.4 Hz, 1H,
CH), 2.55 (d, J = 16.4 Hz, 1H, CH), 5.79 (s, 1H, CH), 7.19
(d, J = 8.4 Hz, 2H, ArH), 7.24 (d, J = 8.4 Hz, 2H, ArH),
7.30–7.34 (m, 2H, ArH), 7.40–7.44 (m, 1H, ArH), 7.79–
7.82 (m, 2H, ArH), 7.90 (d, J = 8.8 Hz, 1H, ArH), 9.77 (s,
1H, NH). IR (KBr, m, cmꢀ1): 3257, 3076, 2956, 2935, 2873,
1684, 1635, 1578, 1540, 1519, 1500, 1429, 1387, 1258, 1248,
1150, 1086, 1013, 843, 820, 748. Anal. Calcd for
C25H22ClNO: C, 77.41; H, 5.72; N, 3.61. Found: C,
77.28; H, 5.80; N, 3.71.
Figure 4. ORTEP diagram of 8a.
Copies of available material can be obtained, free of
charge, on application to the Director, CCDC, 12 Union
Road, Cambridge CB2 1EZ, UK (fax: +44 (0) 1223
336033 ore-mail: deposit@ccdc.cam.ac.uk).
Acknowledgements
We are grateful to the Natural Science Foundation
(04KJB150139) of Jiangsu Education Committee for
financial support.
References and notes
1. (a) Breslow, R.; Rideout, D. C. J. Am. Chem. Soc. 1980,
102, 7816; (b) Breslow, R. Acc. Chem. Res. 1991, 24, 159.
2. Breslow, R.; Maitra, U. Tetrahedron Lett. 1984, 25, 1239.
3. (a) Ponaras, A. A. J. Org. Chem. 1983, 48, 3866; (b)
Coates, R. M.; Rogers, B. D.; Hobbs, S. J.; Peck, D. R.;
Curran, D. P. J. Am. Chem. Soc. 1987, 109, 1160.
4. (a) Mattes, H.; Benezra, C. Tetrahedron Lett. 1985, 26,
5697; (b) Zhou, J. Y.; Lu, G. D.; Wu, S. H. Synth.
Commun. 1992, 22, 481.
16. Villemin, D.; Labiad, B. Synth. Commun. 1990, 20,
3207.
5. Delair, P.; Luche, J. L. J. Chem. Soc., Chem. Commun.
1989, 398.
17. Hu, H. W. Organic Chemistry, 2nd ed.; High Education
Press: Beijing, 2000, p 374.
6. (a) Breslow, R.; Maitra, U.; Rideout, D. C. Tetrahedron
Lett. 1983, 24, 1901; (b) Tan, X. H.; Hou, Y. Q.; Huang,
C.; Liu, L.; Guo, Q. X. Tetrahedron 2004, 60, 6129.
7. (a) Copley, S. D.; Knowles, J. R. J. Am. Chem. Soc. 1987,
109, 5008; (b) Khosropour, A. R.; Khodaei, M. M.;
Kookhazadeh, M. Tetrahedron Lett. 2004, 45, 1725.
8. (a) Janis, R. A.; Silver, P. J.; Triggle, D. J. Adv. Drug Res.
1987, 16, 30; (b) Shan, R.; Velazquez, C.; Knaus, E. E. J.
Med. Chem. 2004, 41, 254; (c) Dulhunty, A. F.; Curtis, S.
M.; Watson, S.; Cengia, L.; Marco, G. J. Biol. Chem.
2004, 279, 11853.
9. Eisner, U.; Kuthan, J. Chem. Rev. 1972, 72, 1.
10. Chorvat, R. J.; Rorig, K. J. J. Org. Chem. 1988, 53, 5779.
11. Sainani, J. B.; Shah, A. C. Indian J. Chem. 1994, 33B, 516.
12. Martin, N.; Quinteiro, M.; Seoane, C.; Mora, L.; Suarez,
M.; Ockoa, E.; Morales, A. J. Heterocycl. Chem. 1995, 51,
235.
18. The general procedure for 7 and 8 is described as follows:
A mixture of Schiff base 4 (2 mmol), meldrumÕs acid
(4 mmol) and TEBA (0.1 g) was suspended in water
(10 mL) and stirred at 100 ꢁC for several hours. Upon
completion, monitored by TLC, the reaction mixture was
allowed to cool to room temperature. The solid was
collected by filtration and washed with water. The solid
was purified by column chromatogaraphy on silica gel
(200–300 mesh) using petroleum ether (bp 60–90ꢁC)–
acetone (1:1) as eluent to give 7 and 8. Compound 7a:
mp 242–243 ꢁC; 1H NMR: d 2.52 (d, J = 14.0 Hz, 1H,
CH), 3.19 (dd, J = 14.0 Hz, J0 = 4.8 Hz, 1H, CH), 5.03 (d,
J = 4.8 Hz, 1H, CH), 7.10 (d, J = 8.4 Hz, 2H, ArH), 7.26–
7.37 (m, 4H, ArH), 7.43 (t, J = 7.6 Hz, 1H, ArH), 7.80 (t,
J = 7.6 Hz, 1H, ArH), 7.85–7.89 (m, 2H, ArH), 10.42 (s,
1H, NH); IR (KBr, m, cmꢀ1): 3196, 3041, 2967, 1676, 1625,
1606, 1524, 1491, 1426, 1243, 1092, 1014, 833, 815, 734.
13. Tu, S. J.; Miao, C. B.; Gao, Y.; Feng, Y. J.; Feng, J. C.
Chin. J. Chem. 2002, 20, 703.